TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

NCT01829464 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
90
Enrollment
INDUSTRY
Sponsor class

Stopped Due to potential concerns about liver safety (See Detailed Description)

Conditions

Interventions

Sponsor

Takeda